Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2013-09-05

Clinical Trial Update: Aspirin Resistance Reversibility in Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating reversibility of aspirin resistance in diabetic patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Azienda Ospedaliera San Giovanni Battista | Conditions: Aspirin Resistance | Phase 4 | Status: UNKNOWN